Table 2.

Prevalence of 5-year absolute risk and lifetimes absolute risk of breast cancer in U.S. women by race and age

A. Prevalence (%) of 5-year absolute risk (%) of breast cancer by race and age in U.S. women
≥1.67%≥2.00%≥3.00%≥4.00%
% (95% CI)% (95% CI)% (95% CI)% (95% CI)
All women
    30-39 y0.0 (0.0-0.2)0.0 (0.0-0.1)0.0 (NA)0.0 (NA)
    40-49 y4.1 (3.6-4.8)1.5 (1.2-1.9)0.3 (0.2-0.5)0.1 (0.0-0.2)
    50-59 y13.3 (12.2-14.5)8.5 (7.6-9.4)1.7 (1.4-2.2)0.8 (0.5-1.1)
    60-69 y36.4 (34.5-38.3)18.0 (16.5-19.5)7.1 (6.2-8.1)2.1 (1.7-2.7)
    70-84 y44.1 (42.4-45.8)21.8 (20.5-23.3)10.0 (9.0-11.1)2.5 (2.0-3.0)
White non-Hispanic
    30-39 y0.1 (0.0-0.2)0.0 (0.0-0.1)0.0 (NA)0.0 (NA)
    40-49 y5.2 (4.5-6.0)1.9 (1.5-2.5)0.3 (0.2-0.6)0.1 (0.0-0.2)
    50-59 y15.5 (14.2-16.9)10.0 (9.1-11.1)2.2 (1.7-2.8)1.0 (0.7-1.4)
    60-69 y39.1 (37.0-41.2)20.6 (18.9-22.5)8.7 (7.6-9.9)2.6 (2.1-3.2)
    70-84 y47.3 (45.4-49.1)25.0 (23.4-26.6)11.8 (10.6-13.1)2.9 (2.4-3.6)
Black non-Hispanic
    30-39 y0.0 (NA)0.0 (NA)0.0 (NA)0.0 (NA)
    40-49 y1.2 (0.6-2.1)0.1 (0.0-0.5)0.0 (NA)0.0 (NA)
    50-59 y8.2 (6.1-10.8)4.7 (2.9-7.1)0.5 (0.1-1.6)0.0 (NA)
    60-69 y36.4 (30.2-43.1)6.7 (3.9-10.5)1.2 (0.3-3.3)0.8 (0.1-3.1)
    70-84 y42.3 (36.8-47.9)7.4 (4.7-11.1)1.6 (0.4-4.0)0.6 (0.0-3.1)
Hispanic
    30-39 y0.0 (NA)0.0 (NA)0.0 (NA)0.0 (NA)
    40-49 y0.5 (0.2-1.1)0.3 (0.0-0.8)0.0 (NA)0.0 (NA)
    50-59 y2.1 (1.2-3.5)0.6 (0.2-1.5)0.1 (0.0-0.7)0.0 (NA)
    60-69 y10.3 (6.6-15.2)6.8 (3.9-11.0)1.0 (0.3-2.5)0.6 (0.1-1.8)
    70-84 y6.9 (4.2-10.6)3.8 (2.1-6.3)0.1 (0.0-1.1)0.1 (0.0-1.1)
B. Prevalence (%) of lifetime absolute risks (%) of breast cancer by race and age in U.S. women
≥6.00%≥8.00%≥10.00%≥12.00%≥14.00%≥16.00%
% (95% CI)% (95% CI)% (95% CI)% (95% CI)% (95% CI)% (95% CI)
All Women
    30-39 y93.5 (92.9-94.1)72.4 (71.2-73.6)47.6 (46.2-48.9)18.3 (17.3-19.4)5.9 (5.2-6.7)4.5 (3.9-5.1)
    40-49 y95.5 (94.9-96.0)69.9 (68.4-71.3)41.8 (40.3-43.2)20.5 (19.5-21.7)10.4 (9.6-11.3)7.0 (6.4-7.8)
    50-59 y81.3 (80.0-82.4)49.6 (48.0-51.2)22.3 (20.9-23.7)12.6 (11.6-13.7)8.9 (8.1-9.9)4.6 (4.0-5.2)
    60-69 y48.9 (47.0-50.8)18.8 (17.3-20.5)10.8 (9.7-12.1)6.4 (5.5-7.4)2.8 (2.3-3.5)2.1 (1.6-2.6)
    70-84 y10.6 (9.6-11.8)4.3 (3.7-5.1)1.7 (1.4-2.2)0.8 (0.6-1.2)0.4 (0.2-0.7)0.3 (0.1-0.5)
White non-Hispanic
    30-39 y100.0 (NA)83.8 (82.5-85.1)63.8 (62.1-65.5)24.4 (23.0-26.0)7.7 (6.7-8.8)6.3 (5.5-7.3)
    40-49 y100.0 (NA)77.6 (76.1-79.0)51.9 (50.2-53.6)25.4 (24.0-26.8)12.8 (11.7-13.9)9.3 (8.4-10.3)
    50-59 y85.2 (83.8-86.4)54.7 (52.8-56.5)26.5 (24.9-28.1)15.2 (14.0-16.5)11.2 (10.1-12.3)5.8 (5.0-6.6)
    60-69 y53.0 (50.8-55.2)21.8 (19.9-23.7)13.0 (11.6-14.5)7.7 (6.7-9.0)3.4 (2.7-4.1)2.4 (1.9-3.1)
    70-84 y12.2 (11.0-13.5)5.0 (4.3-5.9)2.0 (1.6-2.6)1.0 (0.7-1.4)0.5 (0.3-0.9)0.3 (0.1-0.6)
African American non-Hispanic
    30-39 y100.0 (NA)63.9 (60.9-66.8)4.9 (3.8-6.4)2.8 (1.8-4.3)2.8 (1.7-4.2)0.6 (0.2-1.4)
    40-49 y100.0 (NA)68.2 (64.7-71.5)11.8 (9.7-14.2)5.4 (4.0-7.2)4.5 (3.2-6.1)0.5 (0.1-1.3)
    50-59 y88.0 (85.3-90.2)42.8 (39.3-46.4)8.0 (6.0-10.6)4.9 (3.2-7.3)0.7 (0.1-2.0)0.5 (0.1-1.6)
    60-69 y40.6 (35.9-45.4)6.2 (3.8-9.6)3.2 (1.6-5.7)1.2 (0.3-3.3)1.0 (0.1-3.1)1.0 (0.1-3.1)
    70-84 y4.0 (2.0-7.0)0.6 (0.0-3.1)0.6 (0.0-3.1)0.0 (NA)0.0 (NA)0.0 (NA)
Hispanic
    30-39 y55.1 (52.0-58.1)22.0 (19.5-24.8)3.7 (2.7-5.0)2.5 (1.7-3.5)1.0 (0.5-1.9)0.2 (0.0-0.7)
    40-49 y57.4 (53.9-60.9)19.8 (17.2-22.6)8.3 (6.7-10.4)4.8 (3.5-6.6)1.4 (0.7-2.7)0.3 (0.1-0.9)
    50-59 y35.1 (30.4-40.1)11.7 (9.1-14.9)5.8 (3.9-8.3)1.6 (0.8-3.3)0.5 (0.1-1.4)0.5 (0.1-1.4)
    60-69 y15.4 (11.5-20.4)7.0 (4.2-10.9)1.6 (0.6-3.2)1.0 (0.3-2.5)1.0 (0.3-2.5)0.7 (0.1-2.0)
    70-84 y1.0 (0.3-2.6)0.1 (0.0-1.1)0.1 (0.0-1.1)0.1 (0.0-1.1)0.0 (NA)0.0 (NA)